Veterinary Medicines

Marbonor 100 mg/ml Solution for Injection for cattle and pig

Authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
Marbonor 100 mg/ml Solution for Injection for cattle and pig
Marbonor 100mg/ml ενέσιμο διάλυμα για Βοοειδή και Χοίρους
Active substance:
  • Marbofloxacin
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marbofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
    • Pig
      • Meat and offal
        4
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
  • Subcutaneous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • The product is packaged in 60 ml amber co-ex plastic (polypropylene) vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 500 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 250 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 100 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 50 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 20 ml amber type II glass vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 100 ml amber co-ex plastic (polypropylene) vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 250 ml amber co-ex plastic (polypropylene) vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.
  • The product is packaged in 500 ml amber co-ex plastic (polypropylene) vial.Vial is closed with chlorobutyl rubber stopper sealed with aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 21012/02-03-2018/Κ-0196302
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0296/001
Concerned member states:
  • Cyprus
  • Czechia
  • Estonia
  • Finland
  • Greece
  • Hungary
  • Latvia
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."